Home » Newsletters » BioWorld

BioWorld

April 7, 2000

View Archived Issues

Ista Registers For IPO Seeking $86M For Diabetic Drug Vitrase

Sangamo IPO Brings In $52M, Less Than Originally Sought

Other News To Note

Gilead And EyeTech In $32M Deal For Eye Disease Drug

Financings Raise $82M For Cubist, $56M For Ribozyme

With Single Genome Finished, Celera Genomics Stock Soars

Triangles Anti-HIV Drug Trial To Be Halted, Delaying NDA

Surprising Synthetic Pathway Discloses Potential Drugs For African Trypanosomiasis Cure